{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:23:21Z","timestamp":1793057001767,"version":"4.5.0"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T00:00:00Z","timestamp":1728950400000},"content-version":"vor","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001664","name":"The Leibniz Association","doi-asserted-by":"publisher","award":["J59\/2018"],"award-info":[{"award-number":["J59\/2018"]}],"id":[{"id":"10.13039\/501100001664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The standard of care for Lassa fever is the use of ribavirin with supportive therapy. There is little information on the course of viremia and its relationship with clinical outcomes in patients treated with ribavirin.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted a retrospective analysis of virologic and clinical parameters of 152 reverse transcription polymerase chain reaction\u2013confirmed Lassa fever cases admitted and treated with ribavirin therapy. We describe the Lassa virus RNA kinetics in blood in relation to the clinical course of the patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The overall mortality was 9%. The median duration (interquartile range [IQR]) of illness before admission was 8 (5\u201312) days. Median (IQR) Ct values on admission (t0) were lower among patients who died (21 [20\u201327]) than in those who survived (34 [30\u201337]; P &amp;lt; .01). The receiver operating characteristics curve of the association between outcome and Ct value at t0 had a high classification performance, with an AUC of 0.92 (95% CI, 0.86\u20130.98). The median time to viral clearance (IQR) was 10 (5\u201315) days. The viral load decreased steadily with the duration of treatment, and all survivors achieved viral clearance within 25 days of hospitalization.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Our study demonstrates that the Ct value on admission has prognostic value and Lassa fever patients treated with ribavirin typically clear the virus within 3\u20134 weeks of hospitalization. This kinetics has implications for the design of clinical case management and future clinical trial protocols.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofae575","type":"journal-article","created":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T16:43:01Z","timestamp":1729010581000},"source":"Crossref","is-referenced-by-count":11,"title":["Virus Load Kinetics in Lassa Fever Patients Treated With Ribavirin: A Retrospective Cohort Study From Southern Nigeria"],"prefix":"10.1093","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5407-1152","authenticated-orcid":false,"given":"Ephraim","family":"Ogbaini-Emovon","sequence":"first","affiliation":[{"name":"Institute of Viral Haemorrhagic Fever and Emergent Pathogens, Irrua Specialist Teaching Hospital , Irrua ,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Akpede","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Irrua Specialist Teaching Hospital , Irrua ,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvanus","family":"Okogbenin","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Irrua Specialist Teaching Hospital , Irrua ,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Osagiede","sequence":"additional","affiliation":[{"name":"Department of Community, Irrua Specialist Teaching Hospital , Irrua ,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaete","family":"Tobin","sequence":"additional","affiliation":[{"name":"Department of Community, Irrua Specialist Teaching Hospital , Irrua ,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Asogun","sequence":"additional","affiliation":[{"name":"Department of Community, Irrua Specialist Teaching Hospital , Irrua ,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Okokhere","sequence":"additional","affiliation":[{"name":"Department of Medicine, Irrua Specialist Teaching Hospital , Irrua ,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Okonofua","sequence":"additional","affiliation":[{"name":"Institute of Viral Haemorrhagic Fever and Emergent Pathogens, Irrua Specialist Teaching Hospital , Irrua ,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nosa","family":"Akpede","sequence":"additional","affiliation":[{"name":"Department of Community, Irrua Specialist Teaching Hospital , Irrua ,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Akhideno","sequence":"additional","affiliation":[{"name":"Department of Medicine, Irrua Specialist Teaching Hospital , Irrua ,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Erameh","sequence":"additional","affiliation":[{"name":"Department of Medicine, Irrua Specialist Teaching Hospital , Irrua ,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojeed","family":"Rafiu","sequence":"additional","affiliation":[{"name":"Department of Medicine, Irrua Specialist Teaching Hospital , Irrua ,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chukwuemeka","family":"Azubuike","sequence":"additional","affiliation":[{"name":"Department of Medicine, Irrua Specialist Teaching Hospital , Irrua ,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Iraoya","sequence":"additional","affiliation":[{"name":"Department of Medicine, Irrua Specialist Teaching Hospital , Irrua ,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Iruolagbe","sequence":"additional","affiliation":[{"name":"Department of Medicine, Irrua Specialist Teaching Hospital , Irrua ,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Erohubie","sequence":"additional","affiliation":[{"name":"Department of Medicine, Irrua Specialist Teaching Hospital , Irrua ,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dazumi","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Department of Medicine, Irrua Specialist Teaching Hospital , Irrua ,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osahogie","family":"Ediawe","sequence":"additional","affiliation":[{"name":"Institute of Viral Haemorrhagic Fever and Emergent Pathogens, Irrua Specialist Teaching Hospital , Irrua ,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Okoguale","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Irrua Specialist Teaching Hospital , Irrua ,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reuben","family":"Eifediyi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Irrua Specialist Teaching Hospital , Irrua ,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikponmwonsa","family":"Odia","sequence":"additional","affiliation":[{"name":"Institute of Viral Haemorrhagic Fever and Emergent Pathogens, Irrua Specialist Teaching Hospital , Irrua ,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Agbukor","sequence":"additional","affiliation":[{"name":"Institute of Viral Haemorrhagic Fever and Emergent Pathogens, Irrua Specialist Teaching Hospital , Irrua ,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatus","family":"Adomeh","sequence":"additional","affiliation":[{"name":"Institute of Viral Haemorrhagic Fever and Emergent Pathogens, Irrua Specialist Teaching Hospital , Irrua ,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxy A C","family":"Odike","sequence":"additional","affiliation":[{"name":"Department of Histopathology, Irrua Specialist Teaching Hospital, Irrua, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilson","family":"Ovienria","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Irrua Specialist Teaching Hospital , Irrua ,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anieno","family":"Elkanem","sequence":"additional","affiliation":[{"name":"Institute of Viral Haemorrhagic Fever and Emergent Pathogens, Irrua Specialist Teaching Hospital , Irrua ,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekene B","family":"Muoebenam","sequence":"additional","affiliation":[{"name":"Institute of Viral Haemorrhagic Fever and Emergent Pathogens, Irrua Specialist Teaching Hospital , Irrua ,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kingsley C","family":"Ojide","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Alex Ekwemen Federal Teaching Hospital , Abakaliki ,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Pallasch","sequence":"additional","affiliation":[{"name":"Bernhard Nocht Institute for Tropical Medicine , Hamburg ,","place":["Germany"]},{"name":"German Center for Infection Research (DZIF), partner site Hamburg-Borstel-L\u00fcbeck-Riems ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Bernhard Nocht Institute for Tropical Medicine , Hamburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Hinzmann","sequence":"additional","affiliation":[{"name":"Bernhard Nocht Institute for Tropical Medicine , Hamburg ,","place":["Germany"]},{"name":"German Center for Infection Research (DZIF), partner site Hamburg-Borstel-L\u00fcbeck-Riems ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6562-0230","authenticated-orcid":false,"given":"Stephan","family":"G\u00fcnther","sequence":"additional","affiliation":[{"name":"Bernhard Nocht Institute for Tropical Medicine , Hamburg ,","place":["Germany"]},{"name":"German Center for Infection Research (DZIF), partner site Hamburg-Borstel-L\u00fcbeck-Riems ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meike","family":"Pahlmann","sequence":"additional","affiliation":[{"name":"Bernhard Nocht Institute for Tropical Medicine , Hamburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"Thielebein","sequence":"additional","affiliation":[{"name":"Bernhard Nocht Institute for Tropical Medicine , Hamburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Duraffour","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Alex Ekwemen Federal Teaching Hospital , Abakaliki ,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Oestereich","sequence":"additional","affiliation":[{"name":"Bernhard Nocht Institute for Tropical Medicine , Hamburg ,","place":["Germany"]},{"name":"German Center for Infection Research (DZIF), partner site Hamburg-Borstel-L\u00fcbeck-Riems ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Krumkamp","sequence":"additional","affiliation":[{"name":"Bernhard Nocht Institute for Tropical Medicine , Hamburg ,","place":["Germany"]},{"name":"German Center for Infection Research (DZIF), partner site Hamburg-Borstel-L\u00fcbeck-Riems ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,10,15]]},"reference":[{"key":"2024102921305441900_ofae575-B1","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/infdis\/155.3.437","article-title":"A prospective study of the epidemiology and ecology of Lassa fever","volume":"155","author":"McCormick","year":"1987","journal-title":"J Infect Dis"},{"key":"2024102921305441900_ofae575-B2","doi-asserted-by":"crossref","first-page":"e2748","DOI":"10.1371\/journal.pntd.0002748","article-title":"Lassa fever in post-conflict Sierra Leone","volume":"8","author":"Shaffer","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"2024102921305441900_ofae575-B3","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3389\/fpubh.2019.00170","article-title":"Caseload and case fatality of Lassa fever in Nigeria, 2001\u20132018: a specialist center's experience and its implications","volume":"7","author":"Akpede","year":"2019","journal-title":"Front Public Health"},{"key":"2024102921305441900_ofae575-B4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.antiviral.2018.09.009","article-title":"The WHO R&D blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts","volume":"159","author":"Mehand","year":"2018","journal-title":"Antiviral Res"},{"key":"2024102921305441900_ofae575-B5","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/infdis\/155.3.445","article-title":"A case-control study of the clinical diagnosis and course of Lassa fever","volume":"155","author":"McCormick","year":"1987","journal-title":"J Infect Dis"},{"key":"2024102921305441900_ofae575-B6","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1136\/bmj.327.7426.1271","article-title":"Lassa fever: epidemiology, clinical features, and social consequences","volume":"327","author":"Richmond","year":"2003","journal-title":"BMJ"},{"key":"2024102921305441900_ofae575-B7","doi-asserted-by":"crossref","first-page":"e1839","DOI":"10.1371\/journal.pntd.0001839","article-title":"Molecular diagnostics for Lassa fever at Irrua specialist teaching hospital, Nigeria: lessons learnt from two years of laboratory operation","volume":"6","author":"Asogun","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"2024102921305441900_ofae575-B8","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1089\/15303660160025903","article-title":"Lassa fever in Guinea: I. Epidemiology of human disease and clinical observations","volume":"1","author":"Bausch","year":"2001","journal-title":"Vector Borne Zoonotic Dis"},{"key":"2024102921305441900_ofae575-B9","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1136\/bmj.311.7009.857","article-title":"Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice","volume":"311","author":"Fisher-Hoch","year":"1995","journal-title":"BMJ"},{"key":"2024102921305441900_ofae575-B10","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/0035-9203(72)90271-4","article-title":"Epidemiological aspects of the 1970 epidemic, Jos, Nigeria","volume":"66","author":"Carey","year":"1972","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2024102921305441900_ofae575-B11","doi-asserted-by":"crossref","first-page":"780","DOI":"10.4269\/ajtmh.1973.22.780","article-title":"Clinical presentation of Lassa fever cases during the hospital epidemic at Zorzor, Liberia, March\u2013April 1972","volume":"22","author":"Mertens","year":"1973","journal-title":"Am J Trop Med Hyg"},{"key":"2024102921305441900_ofae575-B12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJM198601023140104","article-title":"Lassa fever. Effective therapy with ribavirin","volume":"314","author":"McCormick","year":"1986","journal-title":"N Engl J Med"},{"key":"2024102921305441900_ofae575-B13","volume-title":"National Guideline for Lassa Fever Case Management","author":"Nigeria Centre for Disease Control.","year":"2018"},{"key":"2024102921305441900_ofae575-B14","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.1016\/S2214-109X(20)30518-0","article-title":"Lassa fever outcomes and prognostic factors in Nigeria (LASCOPE): a prospective cohort study","volume":"9","author":"Duvignaud","year":"2021","journal-title":"Lancet Glob Health"},{"key":"2024102921305441900_ofae575-B15","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0168-8278(96)80225-X","article-title":"Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study","volume":"25","author":"Dusheiko","year":"1996","journal-title":"J Hepatol"},{"key":"2024102921305441900_ofae575-B16","first-page":"CD000181","article-title":"Ribavirin for respiratory syncytial virus infection of the lower respiratory tract","author":"Randolph","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"2024102921305441900_ofae575-B17","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/jac\/dkr136","article-title":"Ribavirin for patients with Crimean-Congo haemorrhagic fever: a systematic review and meta-analysis","volume":"66","author":"Ascioglu","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"2024102921305441900_ofae575-B18","volume-title":"WHO Model List of Essential Medicines\u201423rd List","author":"World Health Organization","year":"2023"},{"key":"2024102921305441900_ofae575-B19","doi-asserted-by":"crossref","first-page":"e0009522","DOI":"10.1371\/journal.pntd.0009522","article-title":"Time to reconsider the role of ribavirin in Lassa fever","volume":"15","author":"Salam","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"2024102921305441900_ofae575-B20","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.3201\/eid2808.211787","article-title":"Lack of evidence for ribavirin treatment of Lassa fever in systematic review of published and unpublished studies","volume":"28","author":"Cheng","year":"2022","journal-title":"Emerg Infect Dis"},{"key":"2024102921305441900_ofae575-B21","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S1473-3099(18)30121-X","article-title":"Clinical and laboratory predictors of Lassa fever outcome in a dedicated treatment facility in Nigeria: a retrospective, observational cohort study","volume":"18","author":"Okokhere","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2024102921305441900_ofae575-B22","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S1473-3099(20)30737-4","article-title":"Factors associated with progression to death in patients with Lassa fever in Nigeria: an observational study","volume":"21","author":"Strampe","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"2024102921305441900_ofae575-B23","doi-asserted-by":"crossref","first-page":"e0005711","DOI":"10.1371\/journal.pntd.0005711","article-title":"Prevalence of Lassa virus disease (LVD) in Nigerian children with fever or fever and convulsions in an endemic area","volume":"11","author":"Akhuemokhan","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"2024102921305441900_ofae575-B24","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/trstmh\/tru009","article-title":"Constraints in the diagnosis and treatment of Lassa fever and the effect on mortality in hospitalized children and women with obstetric conditions in a rural district hospital in Sierra Leone","volume":"108","author":"Dahmane","year":"2014","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2024102921305441900_ofae575-B25","doi-asserted-by":"crossref","first-page":"103673","DOI":"10.1016\/j.dib.2019.01.021","article-title":"Data set on Lassa fever in post-conflict Sierra Leone","volume":"23","author":"Shaffer","year":"2019","journal-title":"Data Brief"},{"key":"2024102921305441900_ofae575-B26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5527\/wjn.v4.i1.57","article-title":"Biomarkers in chronic kidney disease, from kidney function to kidney damage","volume":"4","author":"Lopez-Giacoman","year":"2015","journal-title":"World J Nephrol"},{"key":"2024102921305441900_ofae575-B27","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1503\/cmaj.1040752","article-title":"Liver enzyme alteration: a guide for clinicians","volume":"172","author":"Giannini","year":"2005","journal-title":"CMAJ"},{"issue":"Suppl 7","key":"2024102921305441900_ofae575-B28","doi-asserted-by":"crossref","first-page":"S504","DOI":"10.1086\/432007","article-title":"The immunopathogenesis of sepsis in elderly patients","volume":"41","author":"Opal","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2024102921305441900_ofae575-B29","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1086\/427876","article-title":"Insights into severe sepsis in older patients: from epidemiology to evidence-based management","volume":"40","author":"Girard","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2024102921305441900_ofae575-B30","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3390\/diagnostics11061091","article-title":"Viral dynamics and real-time RT-PCR Ct values correlation with disease severity in COVID-19","volume":"11","author":"Rabaan","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"2024102921305441900_ofae575-B31","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/10408360490497456","article-title":"Lassa virus","volume":"41","author":"G\u00fcnther","year":"2004","journal-title":"Crit Rev Clin Lab Sci"},{"key":"2024102921305441900_ofae575-B32","doi-asserted-by":"crossref","first-page":"e1000836","DOI":"10.1371\/journal.ppat.1000836","article-title":"T cell-dependence of Lassa fever pathogenesis","volume":"6","author":"Flatz","year":"2010","journal-title":"PLoS Pathog"},{"key":"2024102921305441900_ofae575-B33","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.23985","article-title":"Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture models","volume":"53","author":"Thomas","year":"2011","journal-title":"Hepatology"},{"key":"2024102921305441900_ofae575-B34","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0168-8278(99)80093-2","article-title":"Ribavirin polarizes human T cell responses towards a type 1 cytokine profile","volume":"30","author":"Tam","year":"1999","journal-title":"J Hepatol"},{"key":"2024102921305441900_ofae575-B35","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1128\/JVI.79.3.1943-1947.2005","article-title":"The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase","volume":"79","author":"Leyssen","year":"2005","journal-title":"J Virol"},{"key":"2024102921305441900_ofae575-B36","doi-asserted-by":"crossref","first-page":"22124","DOI":"10.1074\/jbc.M400908200","article-title":"The broad spectrum antiviral nucleoside ribavirin as a substrate for a viral RNA capping enzyme","volume":"279","author":"Bougie","year":"2004","journal-title":"J Biol Chem"},{"key":"2024102921305441900_ofae575-B37","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1016\/j.celrep.2019.07.099","article-title":"Ribavirin induces polyamine depletion via nucleotide depletion to limit virus replication","volume":"28","author":"Tate","year":"2019","journal-title":"Cell Rep"},{"key":"2024102921305441900_ofae575-B38","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/82191","article-title":"The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen","volume":"6","author":"Crotty","year":"2000","journal-title":"Nat Med"},{"key":"2024102921305441900_ofae575-B39","doi-asserted-by":"crossref","first-page":"e11655","DOI":"10.1371\/journal.pone.0011655","article-title":"Influenza infectious dose may explain the high mortality of the second and third wave of 1918\u20131919 influenza pandemic","volume":"5","author":"Paulo","year":"2010","journal-title":"PLoS One"},{"key":"2024102921305441900_ofae575-B40","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jtbi.2015.03.017","article-title":"The inflammatory response to influenza A virus (H1N1): an experimental and mathematical study","volume":"374","author":"Price","year":"2015","journal-title":"J Theor Biol"},{"key":"2024102921305441900_ofae575-B41","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.coph.2021.07.004","article-title":"Modulation of immune response in Ebola virus disease","volume":"60","author":"Banerjee","year":"2021","journal-title":"Curr Opin Pharmacol"},{"key":"2024102921305441900_ofae575-B42","first-page":"987","article-title":"Host genetic diversity enables Ebola hemorrhagic fever pathogenesis and resistance","volume":"346","author":"Rasmussen","year":"2014","journal-title":"Science (1979)"},{"key":"2024102921305441900_ofae575-B43","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.jiph.2020.07.001","article-title":"Immune response in COVID-19: a review","volume":"13","author":"Chowdhury","year":"2020","journal-title":"J Infect Public Health"},{"key":"2024102921305441900_ofae575-B44","doi-asserted-by":"crossref","first-page":"e0010289","DOI":"10.1371\/journal.pntd.0010289","article-title":"Ribavirin for treating Lassa fever: a systematic review of pre-clinical studies and implications for human dosing","volume":"16","author":"Salam","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"key":"2024102921305441900_ofae575-B45","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.4254\/wjh.v13.i11.1688","article-title":"Abnormal liver enzymes: a review for clinicians","volume":"13","author":"Kalas","year":"2021","journal-title":"World J Hepatol"},{"key":"2024102921305441900_ofae575-B46","volume-title":"The WHO R&D Blueprint: Efficacy Trials of Lassa Therapeutics: Endpoints, Trial Design, Site Selection; WHO Workshop\u2014Final Report","author":"World Health Organization","year":"2018"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofae575\/59761055\/ofae575.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/11\/10\/ofae575\/60199031\/ofae575.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/11\/10\/ofae575\/60199031\/ofae575.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T21:31:20Z","timestamp":1730237480000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofae575\/7822460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":46,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,9,27]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofae575","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,10]]},"published":{"date-parts":[[2024,9,27]]},"article-number":"ofae575"}}